BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31081147)

  • 21. Antitumor activity of the plant extract morin in tongue squamous cell carcinoma cells.
    Ji Y; Jia L; Zhang Y; Xing Y; Wu X; Zhao B; Zhang D; Xu X; Qiao X
    Oncol Rep; 2018 Nov; 40(5):3024-3032. PubMed ID: 30132559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA myocardial infarction associated transcript promotes epithelial-mesenchymal transition and is an independent risk factor for poor prognosis of tongue squamous cell carcinoma.
    Zhong W; Xu Z; Wen S; Xie T; Wang F; Wang Q; Chen J
    J Oral Pathol Med; 2019 Sep; 48(8):720-727. PubMed ID: 31166624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K; Huang Z; Huang Z; He Z; You S
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vitro study of the long non-coding RNA TUG1 in tongue squamous cell carcinoma.
    Li ZQ; Zou R; Ouyang KX; Ai WJ
    J Oral Pathol Med; 2017 Nov; 46(10):956-960. PubMed ID: 28597931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).
    Achmad H; Supriatno ; Singgih MF; Hendrastuti H
    Pak J Biol Sci; 2016; 19(8-9):323-330. PubMed ID: 29023018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.
    Ma T; Zhao Z; Wang Z; Wang C; Zhang L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1359-1369. PubMed ID: 31214736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism].
    Fang Z; Chen S; Zhao JF; Sun Q; Qiu F; Li XM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Sep; 53(9):640-644. PubMed ID: 30196628
    [No Abstract]   [Full Text] [Related]  

  • 30. Hsa_circ_0001742 promotes tongue squamous cell carcinoma progression via modulating miR-634 expression.
    Shao B; He L
    Biochem Biophys Res Commun; 2019 May; 513(1):135-140. PubMed ID: 30944081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cell-derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells.
    Wu YL; Li HY; Zhao XP; Jiao JY; Tang DX; Yan LJ; Wan Q; Pan CB
    Cancer Sci; 2017 May; 108(5):897-909. PubMed ID: 28208216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study.
    Duz MB; Karatas OF; Guzel E; Turgut NF; Yilmaz M; Creighton CJ; Ozen M
    Cell Oncol (Dordr); 2016 Apr; 39(2):187-93. PubMed ID: 26650483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
    He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
    Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA FALEC inhibits proliferation and metastasis of tongue squamous cell carcinoma by epigenetically silencing ECM1 through EZH2.
    Jia B; Xie T; Qiu X; Sun X; Chen J; Huang Z; Zheng X; Wang Z; Zhao J
    Aging (Albany NY); 2019 Jul; 11(14):4990-5007. PubMed ID: 31335317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
    Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
    J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
    Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
    J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of RAB1A in human tongue cancer.
    Shimada K; Uzawa K; Kato M; Endo Y; Shiiba M; Bukawa H; Yokoe H; Seki N; Tanzawa H
    Br J Cancer; 2005 May; 92(10):1915-21. PubMed ID: 15870709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.